{"gene":"BCCIP","run_date":"2026-06-09T22:02:44","timeline":{"discoveries":[{"year":2001,"finding":"BCCIPα was identified as a novel nuclear protein that physically interacts with the internal conserved region of BRCA2 (encoded by exons 14-24). BCCIP is a nuclear protein with three distinct domains (NAD, ICD, CVD), and overexpression of BCCIPα inhibits breast and brain cancer cell growth.","method":"Yeast two-hybrid screen, nuclear localization by subcellular fractionation/immunofluorescence, cell growth inhibition assays","journal":"Oncogene","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — yeast two-hybrid identification plus functional growth inhibition assay, single lab, two orthogonal methods","pmids":["11313963"],"is_preprint":false},{"year":2000,"finding":"TOK-1 (BCCIPα) was identified as a p21(Cip1) C-terminal-binding protein. TOK-1α, but not TOK-1β, directly binds the C-terminal proximal region of p21, forms a ternary complex with CDK2 via p21, and cooperatively enhances p21-dependent inhibitory activity toward CDK2 histone H1 kinase activity.","method":"Yeast two-hybrid cloning, co-immunoprecipitation (ternary complex), in vitro kinase assay (CDK2 histone H1 phosphorylation)","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro kinase assay with functional readout plus co-IP for complex formation, single lab with multiple orthogonal methods","pmids":["10878006"],"is_preprint":false},{"year":2005,"finding":"Both BCCIPα and BCCIPβ isoforms interact with BRCA2 via a shared region. Chromatin-bound BRCA2 colocalizes with BCCIP nuclear foci. RNAi-mediated knockdown of BCCIPα (by 90%) or BCCIPβ (by 50%) markedly reduces RAD51 and BRCA2 nuclear foci and reduces homologous recombinational repair (HRR) of DSBs by 20- to 100-fold.","method":"Co-immunoprecipitation, RNA interference, immunofluorescence colocalization, HRR reporter assay","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 2 / Moderate — reciprocal Co-IP, RNAi knockdown with quantitative HRR assay and focus formation, single lab with multiple orthogonal methods","pmids":["15713648"],"is_preprint":false},{"year":2004,"finding":"BCCIPβ binds p21 and inhibits cell growth; this growth inhibition is partially abrogated in p21-deficient cells. Overexpression of BCCIPβ delays G1-to-S progression and results in elevated p21 expression.","method":"Co-immunoprecipitation, p21-deficient cell rescue experiment, cell cycle analysis (flow cytometry), overexpression assay","journal":"Cell cycle (Georgetown, Tex.)","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP plus epistasis rescue in p21-null cells, single lab, two orthogonal methods","pmids":["14726710"],"is_preprint":false},{"year":2004,"finding":"BCCIP regulates p21 expression through a p53-dependent mechanism. RNAi-mediated partial knockdown of BCCIP reduces p21 levels and impairs G1/S checkpoint activation in response to ionizing radiation; BCCIP was shown to regulate p53 transcriptional activity.","method":"RNA interference, RT-PCR/western blot for p21 levels, G1/S checkpoint assay after ionizing radiation, p53-dependent transcription reporter assay","journal":"Cell cycle (Georgetown, Tex.)","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — RNAi knockdown with defined checkpoint phenotype and p53-reporter epistasis, single lab, multiple methods","pmids":["15539944"],"is_preprint":false},{"year":2006,"finding":"BCCIP is required for p53 transactivation activity. BCCIP knockdown by RNAi in p53 wild-type cells diminishes p53 transactivation without reducing p53 protein levels, inhibits p53 binding to the promoters of p21 and HDM2, and reduces tetrameric p53 formation.","method":"RNA interference, luciferase reporter assay, chromatin immunoprecipitation (ChIP), native PAGE for p53 tetramer assessment","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Strong — RNAi with multiple orthogonal readouts (reporter, ChIP, tetramer), single lab but three independent methods supporting the same conclusion","pmids":["17135243"],"is_preprint":false},{"year":2007,"finding":"Multiple BCCIP domains independently regulate HR. BCCIP fragments interacting with BRCA2 or with p21 each inhibit DSB repair by HR. BCCIP does not affect non-homologous end joining (negative result). Constitutive BCCIP downregulation leads to increased spontaneous ssDNA and DSBs.","method":"Domain deletion/fragment overexpression, HR reporter assay, non-specific DNA integration assay (for NHEJ control), comet assay / ssDNA detection","journal":"Nucleic acids research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — domain-deletion functional dissection with multiple readouts, single lab","pmids":["17947333"],"is_preprint":false},{"year":2007,"finding":"BCCIP downregulation leads to chromosomal polyploidization, centrosome amplification, and abnormal mitotic spindle formation. BCCIP-knockdown cells enter mitosis and retain spindle checkpoint but fail to complete cytokinesis.","method":"RNAi knockdown, chromosome karyotyping, centrosome immunofluorescence, spindle checkpoint assay, live-cell imaging of cytokinesis","journal":"Oncogene","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — RNAi with multiple specific cytological readouts (ploidy, centrosome, cytokinesis), single lab","pmids":["17452982"],"is_preprint":false},{"year":2008,"finding":"RAD51 colocalizes with BCCIP early after ionizing radiation, and with RAD52 later. FRAP analysis shows BCCIP mobility does not change after hydroxyurea or ionizing radiation, whereas RAD52 mobility is reduced more by hydroxyurea. These data indicate temporally distinct RAD51-BCCIP and RAD51-RAD52 responses.","method":"Immunofluorescence colocalization, FRAP (fluorescence recovery after photobleaching)","journal":"Cancer research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct live-cell FRAP plus colocalization with temporal resolution, single lab, two orthogonal methods","pmids":["18413737"],"is_preprint":false},{"year":2008,"finding":"LYRIC/AEG-1 interacts with BCCIP and promotes proteasomal degradation of BCCIPα. Co-expression reduces BCCIPα protein levels, an effect partially abrogated by proteasome inhibition; a truncated LYRIC/AEG-1 lacking the interaction region did not alter BCCIPα levels.","method":"Yeast two-hybrid, co-immunoprecipitation, proteasome inhibitor rescue, truncation mutant analysis","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — Co-IP plus domain truncation and pharmacological rescue, single lab, moderate mechanistic depth","pmids":["18440304"],"is_preprint":false},{"year":2008,"finding":"BCCIP interacts with receptor protein tyrosine phosphatase PTPmu. BCCIP is phosphorylated by Src tyrosine kinase and dephosphorylated by PTPmu in vitro. BCCIP is required for both permissive and repulsive functions of PTPmu in neurite outgrowth.","method":"Yeast two-hybrid, in vitro GST pulldown, in vitro kinase/phosphatase assay, neurite outgrowth assay with BCCIP knockdown","journal":"Journal of cellular biochemistry","confidence":"Medium","confidence_rationale":"Tier 1-2 / Moderate — in vitro kinase/phosphatase assay plus functional neurite outgrowth epistasis, single lab with multiple orthogonal methods","pmids":["18773424"],"is_preprint":false},{"year":2009,"finding":"BCCIP is required for nuclear localization of p21. BCCIP downregulation reduces nuclear p21 and increases cytoplasmic p21. BCCIP-p21 interaction is enhanced in response to DNA damage (measured by FRET). This redistribution is not due to Thr-145 phosphorylation of p21.","method":"FRET (Fluorescence Resonance Energy Transfer), subcellular fractionation, immunofluorescence, RNAi knockdown, exogenous p21 expression","journal":"Cell cycle (Georgetown, Tex.)","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — FRET for interaction plus fractionation for localization, RNAi, single lab with orthogonal methods","pmids":["19713748"],"is_preprint":false},{"year":2011,"finding":"BCCIP deficiency in mouse embryonic fibroblasts causes a ~20-fold increase in sister chromatid union (SCU), 3.5-fold increase in chromatid breaks, reduced repair of irradiation-induced DNA damage, reduced RAD51 protein and nuclear foci, and impaired cell proliferation. p53 deletion cannot rescue embryonic lethality from BCCIP deficiency.","method":"Conditional knockdown transgenic mouse (Cre-LoxP RNAi), chromosome stability analysis, sister chromatid exchange assay, RAD51 immunofluorescence, p53 knockout epistasis","journal":"PLoS genetics","confidence":"High","confidence_rationale":"Tier 2 / Strong — in vivo conditional knockdown mouse model with multiple orthogonal cytological and molecular readouts and genetic epistasis, single lab but comprehensive study","pmids":["21966279"],"is_preprint":false},{"year":2012,"finding":"BCCIP deficiency in the mouse neural system impairs embryonic and postnatal neural development, causing microcephaly and cerebellar defects associated with spontaneous DNA damage and cell death in proliferative neural progenitors. BCCIP deficiency impairs neural progenitor self-renewal and spontaneously activates p53.","method":"Conditional BCCIP knockdown mouse model (Cre-LoxP), neural spheroid culture, immunofluorescence for DNA damage markers, p53 activation assay","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vivo conditional KD with tissue-specific phenotype and in vitro progenitor assay, single lab","pmids":["22292003"],"is_preprint":false},{"year":2013,"finding":"Conditional BCCIP knockdown combined with p53 deletion causes rapid medulloblastoma development with Sonic Hedgehog pathway alterations. Progressed tumors spontaneously lose the BCCIP knockdown cassette and restore BCCIP expression, demonstrating that transient BCCIP downregulation is sufficient to initiate tumorigenesis but BCCIP is required for tumor progression.","method":"Conditional knockdown transgenic mouse model, tumor histology, genomic analysis of Shh pathway, loss of knockdown cassette verification by PCR","journal":"Cancer research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vivo conditional model with molecular verification of cassette loss, single lab","pmids":["24145349"],"is_preprint":false},{"year":2014,"finding":"BCCIPβ, but not BCCIPα, forms a ternary complex with ribosomal protein RPL23/uL14 and pre-60S trans-acting factor eIF6 in a manner dependent on the intact C-terminal domain of BCCIPβ. BCCIPβ depletion reduces the free RPL23 pool and decreases nucleolar eIF6 levels. BCCIPβ overexpression leads to nucleoplasmic accumulation of extra-ribosomal RPL23, indicating BCCIPβ functions as a nuclear chaperone for RPL23.","method":"Co-immunoprecipitation, subcellular fractionation, overexpression/depletion experiments, immunofluorescence","journal":"FEBS letters","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP for ternary complex plus depletion/overexpression with defined molecular phenotypes, single lab","pmids":["25150171"],"is_preprint":false},{"year":2016,"finding":"BCCIPβ directly binds DNA and physically interacts with RAD51 to stimulate its homologous DNA pairing activity. BCCIPβ induces a conformational change within the RAD51 filament that promotes ADP release, thereby helping maintain an active presynaptic filament (stimulation is not due to filament stabilization).","method":"In vitro DNA binding assay, pulldown, in vitro D-loop/strand exchange assay, ATPase assay, filament conformational analysis","journal":"Nucleic acids research","confidence":"High","confidence_rationale":"Tier 1 / Moderate — reconstituted in vitro biochemical assays (DNA pairing, ADP release, conformational change), single lab with multiple orthogonal in vitro methods","pmids":["27694622"],"is_preprint":false},{"year":2016,"finding":"The INO80/YY1 chromatin remodeling complex transcriptionally regulates BCCIP expression. YY1 and INO80 are enriched at +0.17 kb downstream of the BCCIP transcriptional start site. Both INO80 and YY1 are required for recruiting the complex to the BCCIP promoter region; knockdown of either abolishes BCCIP mRNA and protein expression.","method":"siRNA knockdown, luciferase reporter assay, chromatin immunoprecipitation (ChIP), overexpression studies","journal":"Protein & cell","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP plus luciferase reporter and knockdown, single lab with multiple orthogonal methods","pmids":["27535137"],"is_preprint":false},{"year":2017,"finding":"BCCIPα localizes to the mitotic spindle pole and centrosome (proximal to the mother centriole). BCCIP depletion causes disoriented mitotic spindles, chromosome congression defects, and delayed mitotic progression, indicating BCCIP participates in microtubule organization.","method":"Immunofluorescence/confocal microscopy for spindle/centrosome localization, RNAi knockdown, time-lapse imaging of mitotic progression","journal":"Oncogene","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct localization to centrosome/spindle pole plus RNAi phenotype with specific cytological readouts, single lab","pmids":["28394342"],"is_preprint":false},{"year":2018,"finding":"BCCIP directly interacts with YY1 via its ICD domain. BCCIP stabilizes YY1 by reducing YY1 ubiquitination, and YY1 in turn recruits itself to the BCCIP promoter to activate BCCIP transcription (BCCIP-YY1 autoregulatory feedback loop). BCCIP itself binds the BCCIP promoter in a YY1-dependent fashion.","method":"Co-immunoprecipitation, ChIP, luciferase reporter assay, ubiquitination assay, domain mapping with truncation constructs","journal":"The FEBS journal","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP, ChIP, reporter assay, ubiquitination assay, single lab with multiple orthogonal methods","pmids":["29932276"],"is_preprint":false},{"year":2019,"finding":"YY1 and BCCIP coordinately regulate p53-responsive element (p53RE)-mediated transactivation of p21. YY1, BCCIP, and p53 form cross-interacting complexes; YY1 inhibits while BCCIP enhances p53RE-mediated luciferase activity. BCCIP knockdown inhibits p53 and YY1 recruitment to the p53RE proximal region of p21 promoter.","method":"Co-immunoprecipitation, dual luciferase assay, ChIP, lentiviral shRNA knockdown, rescue by YY1 overexpression","journal":"International journal of molecular sciences","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP plus reporter assay and Co-IP, single lab with multiple orthogonal methods","pmids":["31035388"],"is_preprint":false},{"year":2020,"finding":"A fraction of BCCIP localizes in the nucleolus and is required for a pre-rRNA processing step that produces 12S pre-rRNA (precursor to 5.8S rRNA) and for 60S ribosome biogenesis. Abrogation of BCCIP nucleolar localization or impaired BCCIP-eIF6 interaction compromises eIF6 recruitment to the nucleolus and 60S biogenesis.","method":"Subcellular fractionation and immunofluorescence for nucleolar localization, pre-rRNA processing assay (northern blot/PCR), eIF6 interaction mapping, conditional knockout MEFs","journal":"Nucleic acids research","confidence":"High","confidence_rationale":"Tier 2 / Strong — direct nucleolar localization plus functional pre-rRNA processing assay plus eIF6 interaction mapping, single lab with multiple orthogonal methods and in vivo mouse validation","pmids":["33245766"],"is_preprint":false},{"year":2020,"finding":"Complete deletion of Bccip in adult mouse intestinal epithelium causes rapid epithelial denudation (not rescued by Trp53 co-deletion), loss of proliferative capability of crypt progenitors, loss of crypt base columnar stem cell markers, and failure of crypt organoid growth in vitro. RNA-Seq showed overwhelming down-regulation of mitotic division genes.","method":"Conditional knockout mouse (Rosa26-CreERT2, Villin-CreERT2), crypt organoid culture, immunofluorescence, RNA-Seq","journal":"The American journal of pathology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vivo conditional knockout with tissue-specific phenotype plus in vitro organoid assay and RNA-Seq, single lab","pmids":["33039352"],"is_preprint":false},{"year":2021,"finding":"Crystal structures of N-terminal truncated human BCCIPβ (residues 61-314) show structural similarity to GCN5-related acetyltransferases (GNATs) but with altered acetyl-CoA and substrate-binding grooves. BCCIPβ contains a large 19-residue flap that adopts open or closed conformations and a positively charged, reduced substrate binding groove, suggesting binding sites for partner proteins.","method":"X-ray crystallography (two crystal structures solved)","journal":"Protein science : a publication of the Protein Society","confidence":"High","confidence_rationale":"Tier 1 / Moderate — crystal structure determination with structural analysis of functional sites, single lab rigorous structural study","pmids":["33452718"],"is_preprint":false},{"year":2022,"finding":"BCCIP is recruited to stalled replication forks and prevents MRE11 nuclease-mediated degradation of nascent DNA strands. BCCIP deficiency increases replication fork stalling and results in DNA double-strand break formation under replication stress.","method":"DNA fiber assay, iPOND (or proximity-ligation assay for fork recruitment), MRE11 inhibitor/knockdown epistasis, γH2AX staining","journal":"FEBS letters","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — DNA fiber assay plus epistasis with MRE11, single lab with defined molecular mechanism","pmids":["35592921"],"is_preprint":false},{"year":2023,"finding":"BCCIPα, but not BCCIPβ, binds FAM46 (TENT5) family noncanonical poly(A) polymerases and inhibits their PAP activity. Crystal structures of FAM46A/BCCIPα and FAM46C/BCCIPα complexes show BCCIPα adopts a unique fold (completely different from BCCIPβ) due to its distinct C-terminal segment; a helix-loop-helix segment in BCCIPα inserts into the active site cleft of FAM46 to inhibit PAP activity. The distinct C-terminal segment supports fold adoption but does not directly contact FAM46.","method":"X-ray crystallography (two complex structures), in vitro PAP activity assay, domain mutagenesis, isoform-specific binding assay","journal":"Science advances","confidence":"High","confidence_rationale":"Tier 1 / Strong — crystal structure of two distinct complexes plus in vitro enzymatic inhibition assay and mutagenesis, single lab but multiple rigorous orthogonal methods","pmids":["37018411"],"is_preprint":false}],"current_model":"BCCIP is a nuclear protein that exists as two alternatively spliced isoforms (BCCIPα and BCCIPβ) with shared ICD but distinct C-terminal domains: BCCIPα uniquely folds to bind and inhibit FAM46/TENT5 poly(A) polymerases and localizes to mitotic spindle poles, while BCCIPβ acts as a nuclear chaperone for RPL23 and directly stimulates RAD51 homologous pairing by inducing ADP release from the presynaptic filament; both isoforms interact with BRCA2 and p21 to promote RAD51/BRCA2 focus formation, homologous recombination repair of DSBs, protection of nascent DNA at stalled replication forks, p53 tetramerization and transactivation of p21, and G1/S checkpoint control, while a fraction of BCCIP localizes to the nucleolus to interact with eIF6 and drive 12S pre-rRNA processing and 60S ribosome biogenesis, explaining why partial BCCIP loss triggers genomic instability and tumorigenesis whereas complete loss is lethal."},"narrative":{"mechanistic_narrative":"BCCIP is a nuclear protein that integrates DNA double-strand break repair, cell-cycle checkpoint control, ribosome biogenesis, and mitotic fidelity, and exists as two alternatively spliced isoforms (BCCIPα/TOK-1α and BCCIPβ) sharing an internal conserved domain but differing in their C-termini [PMID:11313963, PMID:15713648]. Through a shared region both isoforms bind the internal conserved region of BRCA2, and their depletion sharply reduces RAD51 and BRCA2 nuclear focus formation and homologous recombination repair of DSBs without affecting non-homologous end joining [PMID:11313963, PMID:15713648, PMID:17947333]. BCCIPβ acts directly at the recombination step: it binds DNA and RAD51 and stimulates RAD51 homologous pairing by inducing a filament conformational change that promotes ADP release to maintain an active presynaptic filament [PMID:27694622]. Beyond canonical break repair, BCCIP is recruited to stalled replication forks and protects nascent DNA from MRE11-mediated degradation [PMID:35592921]. In cell-cycle control, the α isoform binds the C-terminus of p21 and cooperatively enhances p21-dependent inhibition of CDK2, while BCCIP is required for nuclear localization of p21, for p53 tetramerization, and for p53-dependent transactivation of p21 and HDM2, thereby enforcing the G1/S checkpoint after ionizing radiation [PMID:10878006, PMID:17135243, PMID:19713748]. The two isoforms are also functionally specialized in other compartments: BCCIPβ serves as a nuclear chaperone for ribosomal protein RPL23/uL14 and, in the nucleolus, drives 12S pre-rRNA processing and 60S ribosome biogenesis through recruitment of eIF6 [PMID:25150171, PMID:33245766], whereas BCCIPα localizes to the mitotic spindle pole and centrosome and binds and inhibits FAM46/TENT5 poly(A) polymerases via an isoform-specific fold [PMID:28394342, PMID:37018411]. BCCIP expression is set by an INO80/YY1-driven autoregulatory transcriptional circuit [PMID:27535137, PMID:29932276]. In vivo, partial BCCIP loss produces genomic instability, chromosomal aberrations, and tumorigenesis, while complete loss is lethal to proliferative tissues and is not rescued by p53 deletion [PMID:21966279, PMID:24145349, PMID:33039352].","teleology":[{"year":2000,"claim":"Established the first molecular partner of the α isoform, defining BCCIP as a CDK-inhibitory cofactor by showing it strengthens p21 action.","evidence":"Yeast two-hybrid cloning, ternary-complex co-IP, and in vitro CDK2 histone H1 kinase assay","pmids":["10878006"],"confidence":"High","gaps":["Did not address the β isoform or DNA-repair roles","No structural basis for the p21 interaction"]},{"year":2001,"claim":"Identified BCCIPα as a BRCA2-interacting nuclear protein whose overexpression suppresses cancer cell growth, linking BCCIP to the BRCA2 axis and tumor suppression.","evidence":"Yeast two-hybrid, subcellular fractionation/immunofluorescence, growth inhibition assays","pmids":["11313963"],"confidence":"Medium","gaps":["Functional consequence of the BRCA2 interaction not yet tested","Domain architecture defined but functions of NAD/ICD/CVD unassigned"]},{"year":2004,"claim":"Connected BCCIP to checkpoint control by showing it regulates p21 in a p53-dependent manner and that the β isoform delays G1/S progression.","evidence":"RNAi knockdown, p21-null rescue, flow cytometry, p53 reporter assay after ionizing radiation","pmids":["14726710","15539944"],"confidence":"Medium","gaps":["Mechanism of p53 regulation unresolved at this stage","Did not separate checkpoint role from repair role"]},{"year":2005,"claim":"Demonstrated that both isoforms bind BRCA2 and are quantitatively required for RAD51/BRCA2 focus formation and HRR, placing BCCIP functionally in the homologous recombination pathway.","evidence":"Reciprocal co-IP, RNAi, immunofluorescence colocalization, HRR reporter assay","pmids":["15713648"],"confidence":"High","gaps":["Whether BCCIP acts directly on RAD51 or via BRCA2 not yet distinguished","Step in HR affected unknown"]},{"year":2006,"claim":"Resolved the p53 regulatory mechanism by showing BCCIP is required for p53 tetramerization and promoter binding rather than p53 stabilization.","evidence":"RNAi, luciferase reporter, ChIP, native PAGE for tetramer assessment","pmids":["17135243"],"confidence":"High","gaps":["How BCCIP promotes tetramer formation mechanistically unknown","Direct vs indirect p53 contact not established"]},{"year":2007,"claim":"Dissected BCCIP domains in HR and revealed that its loss drives genomic instability through spindle/centrosome defects and failed cytokinesis, broadening its role beyond repair.","evidence":"Domain-fragment overexpression with HR/NHEJ reporters and comet assay; RNAi with karyotyping, centrosome IF, and cytokinesis imaging","pmids":["17947333","17452982"],"confidence":"Medium","gaps":["Molecular target at the spindle/centrosome unidentified","Link between repair defect and ploidy defect not mechanistically connected"]},{"year":2008,"claim":"Defined temporal dynamics of BCCIP at damage sites and identified upstream and signaling partners (LYRIC/AEG-1 degradation, PTPmu/Src phosphorylation).","evidence":"Immunofluorescence/FRAP at damage sites; co-IP, proteasome rescue, in vitro kinase/phosphatase assays, neurite outgrowth assay","pmids":["18413737","18440304","18773424"],"confidence":"Medium","gaps":["Physiological significance of Src/PTPmu phosphorylation unclear","How AEG-1-driven degradation is regulated in vivo unknown"]},{"year":2009,"claim":"Showed BCCIP controls the subcellular distribution of p21, with a DNA-damage-enhanced interaction driving p21 nuclear retention independent of Thr-145 phosphorylation.","evidence":"FRET, subcellular fractionation, immunofluorescence, RNAi","pmids":["19713748"],"confidence":"Medium","gaps":["Mechanism by which damage enhances the interaction unknown","Transport machinery involved not identified"]},{"year":2011,"claim":"Provided in vivo confirmation that BCCIP maintains chromosome stability and RAD51 function, and that its essentiality is p53-independent.","evidence":"Conditional knockdown mouse, sister chromatid union/break analysis, RAD51 IF, p53 knockout epistasis","pmids":["21966279"],"confidence":"High","gaps":["Cause of p53-independent lethality not defined","Tissue specificity of phenotype not yet explored"]},{"year":2013,"claim":"Established BCCIP as a tumor suppressor whose transient loss initiates medulloblastoma but whose expression is required for tumor progression.","evidence":"Conditional knockdown mouse with p53 deletion, tumor histology, Shh pathway analysis, cassette-loss verification","pmids":["24145349","22292003"],"confidence":"Medium","gaps":["Mechanism linking BCCIP loss to Shh alterations unknown","Why progression requires BCCIP re-expression not resolved"]},{"year":2014,"claim":"Identified an isoform-specific role for BCCIPβ as a nuclear chaperone for RPL23 acting with eIF6, first connecting BCCIP to ribosome biogenesis.","evidence":"Co-IP of ternary complex, fractionation, overexpression/depletion, immunofluorescence","pmids":["25150171"],"confidence":"Medium","gaps":["Effect on mature ribosome output not measured here","Whether chaperone role contributes to genomic-instability phenotype unknown"]},{"year":2016,"claim":"Provided the mechanistic basis for BCCIP's HR function and revealed transcriptional control of the gene by INO80/YY1.","evidence":"Reconstituted in vitro DNA-binding, strand-exchange, ATPase, and filament conformation assays; siRNA, ChIP, reporter assays","pmids":["27694622","27535137"],"confidence":"High","gaps":["How BCCIPβ recognizes the presynaptic filament structurally not determined","Integration of transcriptional control with damage signaling unknown"]},{"year":2017,"claim":"Localized BCCIPα to the mitotic spindle pole/centrosome, assigning a direct mitotic role to the α isoform.","evidence":"Confocal IF localization, RNAi, time-lapse mitotic imaging","pmids":["28394342"],"confidence":"Medium","gaps":["Spindle-pole binding partner not identified","Mechanism of microtubule organization unresolved"]},{"year":2019,"claim":"Detailed the BCCIP-YY1 regulatory circuit, including an autoregulatory feedback loop and coordinate control of p53RE-mediated p21 transactivation.","evidence":"Co-IP, ChIP, reporter and ubiquitination assays, domain mapping, shRNA with rescue","pmids":["29932276","31035388"],"confidence":"Medium","gaps":["How opposing YY1/BCCIP effects on p53RE are balanced unknown","In vivo relevance of the feedback loop not tested"]},{"year":2020,"claim":"Defined BCCIP's nucleolar role in 12S pre-rRNA processing and 60S biogenesis and showed that complete loss is catastrophic for proliferative stem/progenitor tissue.","evidence":"Fractionation/IF, pre-rRNA processing assay, eIF6 interaction mapping, conditional knockout MEFs and intestinal epithelium with organoids and RNA-Seq","pmids":["33245766","33039352"],"confidence":"High","gaps":["Whether the ribosome defect underlies the lethality of complete loss not directly tested","Relationship between nucleolar and repair functions unresolved"]},{"year":2021,"claim":"Provided the first structure of BCCIPβ, revealing a GNAT-like fold with altered substrate/cofactor grooves and a conformationally dynamic flap implicated in partner binding.","evidence":"Two X-ray crystal structures of N-terminally truncated BCCIPβ","pmids":["33452718"],"confidence":"High","gaps":["No demonstrated acetyltransferase activity despite GNAT similarity","Partner-bound structures not solved"]},{"year":2022,"claim":"Extended BCCIP's genome-protective role to replication stress by showing it shields nascent DNA from MRE11 nuclease at stalled forks.","evidence":"DNA fiber assay, MRE11 epistasis, γH2AX staining","pmids":["35592921"],"confidence":"Medium","gaps":["Mechanism of fork recruitment not defined","Which isoform mediates fork protection unknown"]},{"year":2023,"claim":"Defined the structural basis for isoform divergence, showing BCCIPα adopts a unique fold that inhibits FAM46/TENT5 poly(A) polymerases, a function exclusive to the α isoform.","evidence":"Crystal structures of FAM46A/C–BCCIPα complexes, in vitro PAP assays, mutagenesis, isoform-specific binding","pmids":["37018411"],"confidence":"High","gaps":["Cellular consequences of FAM46 inhibition by BCCIPα untested","How the α-specific function integrates with mitotic localization unknown"]},{"year":null,"claim":"How BCCIP's distinct activities — HR stimulation, replication-fork protection, p53/p21 checkpoint control, ribosome biogenesis, mitotic spindle organization, and FAM46 inhibition — are coordinated within a cell and which is rate-limiting for the essentiality and tumor-suppressor phenotypes remains unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No unified model reconciling the multiple compartment-specific functions","Biochemical activity of the GNAT-like fold undefined","Relative contribution of each function to lethality vs tumorigenesis unknown"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0003677","term_label":"DNA binding","supporting_discovery_ids":[16]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[1,16,25]},{"term_id":"GO:0044183","term_label":"protein folding chaperone","supporting_discovery_ids":[15]},{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[5,20]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[0,2]},{"term_id":"GO:0005730","term_label":"nucleolus","supporting_discovery_ids":[15,21]},{"term_id":"GO:0005815","term_label":"microtubule organizing center","supporting_discovery_ids":[18]},{"term_id":"GO:0005654","term_label":"nucleoplasm","supporting_discovery_ids":[11,15]}],"pathway":[{"term_id":"R-HSA-73894","term_label":"DNA Repair","supporting_discovery_ids":[2,6,16]},{"term_id":"R-HSA-1640170","term_label":"Cell Cycle","supporting_discovery_ids":[3,4,7,18]},{"term_id":"R-HSA-8953854","term_label":"Metabolism of RNA","supporting_discovery_ids":[15,21]},{"term_id":"R-HSA-69306","term_label":"DNA Replication","supporting_discovery_ids":[24]},{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[5,17,19,20]}],"complexes":[],"partners":["BRCA2","RAD51","CDKN1A","TP53","YY1","RPL23","EIF6","FAM46C"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q9P287","full_name":"BRCA2 and CDKN1A-interacting protein","aliases":["P21- and CDK-associated protein 1","Protein TOK-1"],"length_aa":314,"mass_kda":36.0,"function":"During interphase, required for microtubule organizing and anchoring activities. During mitosis, required for the organization and stabilization of the spindle pole (PubMed:28394342). Isoform 2/alpha is particularly important for the regulation of microtubule anchoring, microtubule stability, spindle architecture and spindle orientation, compared to isoform 1/beta (PubMed:28394342). May promote cell cycle arrest by enhancing the inhibition of CDK2 activity by CDKN1A. May be required for repair of DNA damage by homologous recombination in conjunction with BRCA2. May not be involved in non-homologous end joining (NHEJ)","subcellular_location":"Cytoplasm, cytoskeleton, microtubule organizing center, centrosome; Cytoplasm, cytoskeleton, spindle pole","url":"https://www.uniprot.org/uniprotkb/Q9P287/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":true,"resolved_as":"","url":"https://depmap.org/portal/gene/BCCIP","classification":"Common Essential","n_dependent_lines":566,"n_total_lines":1208,"dependency_fraction":0.4685430463576159},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[{"gene":"NPM1","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/search/BCCIP","total_profiled":1310},"omim":[{"mim_id":"611883","title":"BRCA2- AND CDKN1A-INTERACTING PROTEIN; BCCIP","url":"https://www.omim.org/entry/611883"},{"mim_id":"607960","title":"DEAH-BOX HELICASE 32, PUTATIVE; DHX32","url":"https://www.omim.org/entry/607960"},{"mim_id":"606938","title":"UROPORPHYRINOGEN III SYNTHASE; UROS","url":"https://www.omim.org/entry/606938"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Nucleoplasm","reliability":"Approved"},{"location":"Cytosol","reliability":"Additional"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/BCCIP"},"hgnc":{"alias_symbol":["BCCIPalpha","TOK-1"],"prev_symbol":[]},"alphafold":{"accession":"Q9P287","domains":[{"cath_id":"3.40.630,3.40.630","chopping":"62-112_120-232_243-314","consensus_level":"medium","plddt":90.4564,"start":62,"end":314}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9P287","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q9P287-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q9P287-F1-predicted_aligned_error_v6.png","plddt_mean":79.38},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=BCCIP","jax_strain_url":"https://www.jax.org/strain/search?query=BCCIP"},"sequence":{"accession":"Q9P287","fasta_url":"https://rest.uniprot.org/uniprotkb/Q9P287.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q9P287/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9P287"}},"corpus_meta":[{"pmid":"11313963","id":"PMC_11313963","title":"Inhibition of breast and brain cancer cell growth by BCCIPalpha, an evolutionarily conserved nuclear protein that interacts with BRCA2.","date":"2001","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/11313963","citation_count":81,"is_preprint":false},{"pmid":"15713648","id":"PMC_15713648","title":"The BRCA2-interacting protein BCCIP functions in RAD51 and BRCA2 focus formation and homologous recombinational repair.","date":"2005","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/15713648","citation_count":72,"is_preprint":false},{"pmid":"10878006","id":"PMC_10878006","title":"TOK-1, a novel p21Cip1-binding protein that cooperatively enhances p21-dependent inhibitory activity toward CDK2 kinase.","date":"2000","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10878006","citation_count":70,"is_preprint":false},{"pmid":"18440304","id":"PMC_18440304","title":"LYRIC/AEG-1 overexpression modulates BCCIPalpha protein levels in prostate tumor cells.","date":"2008","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/18440304","citation_count":57,"is_preprint":false},{"pmid":"18413737","id":"PMC_18413737","title":"Distinct RAD51 associations with RAD52 and BCCIP in response to DNA damage and replication stress.","date":"2008","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/18413737","citation_count":48,"is_preprint":false},{"pmid":"12527204","id":"PMC_12527204","title":"Genomic structure of the human BCCIP gene and its expression in cancer.","date":"2003","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/12527204","citation_count":44,"is_preprint":false},{"pmid":"17947333","id":"PMC_17947333","title":"BCCIP regulates homologous recombination by distinct domains and suppresses spontaneous DNA damage.","date":"2007","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/17947333","citation_count":42,"is_preprint":false},{"pmid":"17452982","id":"PMC_17452982","title":"Roles of BCCIP in chromosome stability and cytokinesis.","date":"2007","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/17452982","citation_count":41,"is_preprint":false},{"pmid":"14726710","id":"PMC_14726710","title":"Inhibition of G1 to S cell cycle progression by BCCIP beta.","date":"2004","source":"Cell cycle (Georgetown, Tex.)","url":"https://pubmed.ncbi.nlm.nih.gov/14726710","citation_count":34,"is_preprint":false},{"pmid":"17135243","id":"PMC_17135243","title":"Abrogation of the transactivation activity of p53 by BCCIP down-regulation.","date":"2006","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/17135243","citation_count":33,"is_preprint":false},{"pmid":"15539944","id":"PMC_15539944","title":"BCCIP functions through p53 to regulate the expression of p21Waf1/Cip1.","date":"2004","source":"Cell cycle (Georgetown, Tex.)","url":"https://pubmed.ncbi.nlm.nih.gov/15539944","citation_count":31,"is_preprint":false},{"pmid":"25150171","id":"PMC_25150171","title":"The beta-isoform of the BRCA2 and CDKN1A(p21)-interacting protein (BCCIP) stabilizes nuclear RPL23/uL14.","date":"2014","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/25150171","citation_count":28,"is_preprint":false},{"pmid":"24145349","id":"PMC_24145349","title":"BCCIP suppresses tumor initiation but is required for tumor progression.","date":"2013","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/24145349","citation_count":28,"is_preprint":false},{"pmid":"19713748","id":"PMC_19713748","title":"BCCIP is required for the nuclear localization of the p21 protein.","date":"2009","source":"Cell cycle (Georgetown, Tex.)","url":"https://pubmed.ncbi.nlm.nih.gov/19713748","citation_count":24,"is_preprint":false},{"pmid":"21966279","id":"PMC_21966279","title":"Essential roles of BCCIP in mouse embryonic development and structural stability of chromosomes.","date":"2011","source":"PLoS genetics","url":"https://pubmed.ncbi.nlm.nih.gov/21966279","citation_count":24,"is_preprint":false},{"pmid":"28386336","id":"PMC_28386336","title":"Celecoxib enhances the radiosensitivity of HCT116 cells in a COX-2 independent manner by up-regulating BCCIP.","date":"2017","source":"American journal of translational research","url":"https://pubmed.ncbi.nlm.nih.gov/28386336","citation_count":24,"is_preprint":false},{"pmid":"19653894","id":"PMC_19653894","title":"Alterations of BCCIP, a BRCA2 interacting protein, in astrocytomas.","date":"2009","source":"BMC cancer","url":"https://pubmed.ncbi.nlm.nih.gov/19653894","citation_count":23,"is_preprint":false},{"pmid":"27535137","id":"PMC_27535137","title":"Human INO80/YY1 chromatin remodeling complex transcriptionally regulates the BRCA2- and CDKN1A-interacting protein (BCCIP) in cells.","date":"2016","source":"Protein & cell","url":"https://pubmed.ncbi.nlm.nih.gov/27535137","citation_count":22,"is_preprint":false},{"pmid":"28394342","id":"PMC_28394342","title":"Regulation of spindle integrity and mitotic fidelity by BCCIP.","date":"2017","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/28394342","citation_count":21,"is_preprint":false},{"pmid":"33245766","id":"PMC_33245766","title":"BCCIP is required for nucleolar recruitment of eIF6 and 12S pre-rRNA production during 60S ribosome biogenesis.","date":"2020","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/33245766","citation_count":19,"is_preprint":false},{"pmid":"27694622","id":"PMC_27694622","title":"The β-isoform of BCCIP promotes ADP release from the RAD51 presynaptic filament and enhances homologous DNA pairing.","date":"2016","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/27694622","citation_count":19,"is_preprint":false},{"pmid":"22292003","id":"PMC_22292003","title":"Requirement of mouse BCCIP for neural development and progenitor proliferation.","date":"2012","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/22292003","citation_count":18,"is_preprint":false},{"pmid":"37018411","id":"PMC_37018411","title":"Inhibition of FAM46/TENT5 activity by BCCIPα adopting a unique fold.","date":"2023","source":"Science advances","url":"https://pubmed.ncbi.nlm.nih.gov/37018411","citation_count":13,"is_preprint":false},{"pmid":"17627904","id":"PMC_17627904","title":"Ortholog of BRCA2-interacting protein BCCIP controls morphogenetic responses during DNA replication stress in Ustilago maydis.","date":"2007","source":"DNA repair","url":"https://pubmed.ncbi.nlm.nih.gov/17627904","citation_count":12,"is_preprint":false},{"pmid":"18773424","id":"PMC_18773424","title":"BCCIP associates with the receptor protein tyrosine phosphatase PTPmu.","date":"2008","source":"Journal of cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/18773424","citation_count":10,"is_preprint":false},{"pmid":"31035388","id":"PMC_31035388","title":"YY1/BCCIP Coordinately Regulates P53-Responsive Element (p53RE)-Mediated Transactivation of p21Waf1/Cip1.","date":"2019","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/31035388","citation_count":10,"is_preprint":false},{"pmid":"29047390","id":"PMC_29047390","title":"Roles of BCCIP deficiency in mammary tumorigenesis.","date":"2017","source":"Breast cancer research : BCR","url":"https://pubmed.ncbi.nlm.nih.gov/29047390","citation_count":8,"is_preprint":false},{"pmid":"33452718","id":"PMC_33452718","title":"Structure of human BCCIP and implications for binding and modification of partner proteins.","date":"2021","source":"Protein science : a publication of the Protein Society","url":"https://pubmed.ncbi.nlm.nih.gov/33452718","citation_count":6,"is_preprint":false},{"pmid":"29932276","id":"PMC_29932276","title":"BCCIP binds to and activates its promoter in a YY1-dependent fashion in HCT116 cells.","date":"2018","source":"The FEBS journal","url":"https://pubmed.ncbi.nlm.nih.gov/29932276","citation_count":6,"is_preprint":false},{"pmid":"30826413","id":"PMC_30826413","title":"The Penaeus stylirostris densovirus capsid protein interacts with the Litopenaeus vannamei BCCIP protein.","date":"2019","source":"Fish & shellfish immunology","url":"https://pubmed.ncbi.nlm.nih.gov/30826413","citation_count":6,"is_preprint":false},{"pmid":"27995408","id":"PMC_27995408","title":"High Expression of BCCIP β Can Promote Proliferation of Esophageal Squamous Cell Carcinoma.","date":"2016","source":"Digestive diseases and sciences","url":"https://pubmed.ncbi.nlm.nih.gov/27995408","citation_count":5,"is_preprint":false},{"pmid":"23911796","id":"PMC_23911796","title":"Mutation analysis of the BCCIP gene for breast cancer susceptibility in breast/ovarian cancer families.","date":"2013","source":"Gynecologic oncology","url":"https://pubmed.ncbi.nlm.nih.gov/23911796","citation_count":4,"is_preprint":false},{"pmid":"35592921","id":"PMC_35592921","title":"The BRCA2 and CDKN1A-interacting protein (BCCIP) stabilizes stalled replication forks and prevents degradation of nascent DNA.","date":"2022","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/35592921","citation_count":3,"is_preprint":false},{"pmid":"38342812","id":"PMC_38342812","title":"Expression and Significance of BCCIP and Glutathione Peroxidase 4 in Clear Cell Renal Cell Carcinoma.","date":"2024","source":"Bulletin of experimental biology and medicine","url":"https://pubmed.ncbi.nlm.nih.gov/38342812","citation_count":2,"is_preprint":false},{"pmid":"33039352","id":"PMC_33039352","title":"Requirement of Bccip for the Regeneration of Intestinal Progenitors.","date":"2020","source":"The American journal of pathology","url":"https://pubmed.ncbi.nlm.nih.gov/33039352","citation_count":2,"is_preprint":false},{"pmid":"40135061","id":"PMC_40135061","title":"Combined targeting of TCF7L1/2, PTEN, CDK6, and BCCIP by microRNA miR-29c-3p is associated with reduced invasion and proliferation of endometriotic cells.","date":"2025","source":"Reproductive medicine and biology","url":"https://pubmed.ncbi.nlm.nih.gov/40135061","citation_count":1,"is_preprint":false},{"pmid":null,"id":"bio_10.1101_2024.06.24.600220","title":"Modulation of ribosomal subunit associations by eIF6 is critical for mitotic exit and cancer progression","date":"2024-06-24","source":"bioRxiv","url":"https://doi.org/10.1101/2024.06.24.600220","citation_count":0,"is_preprint":true}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":18859,"output_tokens":6422,"usd":0.076453,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":15536,"output_tokens":5465,"usd":0.107152,"stage2_stop_reason":"end_turn"},"total_usd":0.183605,"stage1_batch_id":"msgbatch_0179Z2pxRYBsXi2xADneafRw","stage2_batch_id":"msgbatch_01LaY9ZaVdgjWArcZo9eqQE5","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2001,\n      \"finding\": \"BCCIPα was identified as a novel nuclear protein that physically interacts with the internal conserved region of BRCA2 (encoded by exons 14-24). BCCIP is a nuclear protein with three distinct domains (NAD, ICD, CVD), and overexpression of BCCIPα inhibits breast and brain cancer cell growth.\",\n      \"method\": \"Yeast two-hybrid screen, nuclear localization by subcellular fractionation/immunofluorescence, cell growth inhibition assays\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — yeast two-hybrid identification plus functional growth inhibition assay, single lab, two orthogonal methods\",\n      \"pmids\": [\"11313963\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"TOK-1 (BCCIPα) was identified as a p21(Cip1) C-terminal-binding protein. TOK-1α, but not TOK-1β, directly binds the C-terminal proximal region of p21, forms a ternary complex with CDK2 via p21, and cooperatively enhances p21-dependent inhibitory activity toward CDK2 histone H1 kinase activity.\",\n      \"method\": \"Yeast two-hybrid cloning, co-immunoprecipitation (ternary complex), in vitro kinase assay (CDK2 histone H1 phosphorylation)\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro kinase assay with functional readout plus co-IP for complex formation, single lab with multiple orthogonal methods\",\n      \"pmids\": [\"10878006\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Both BCCIPα and BCCIPβ isoforms interact with BRCA2 via a shared region. Chromatin-bound BRCA2 colocalizes with BCCIP nuclear foci. RNAi-mediated knockdown of BCCIPα (by 90%) or BCCIPβ (by 50%) markedly reduces RAD51 and BRCA2 nuclear foci and reduces homologous recombinational repair (HRR) of DSBs by 20- to 100-fold.\",\n      \"method\": \"Co-immunoprecipitation, RNA interference, immunofluorescence colocalization, HRR reporter assay\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal Co-IP, RNAi knockdown with quantitative HRR assay and focus formation, single lab with multiple orthogonal methods\",\n      \"pmids\": [\"15713648\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"BCCIPβ binds p21 and inhibits cell growth; this growth inhibition is partially abrogated in p21-deficient cells. Overexpression of BCCIPβ delays G1-to-S progression and results in elevated p21 expression.\",\n      \"method\": \"Co-immunoprecipitation, p21-deficient cell rescue experiment, cell cycle analysis (flow cytometry), overexpression assay\",\n      \"journal\": \"Cell cycle (Georgetown, Tex.)\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP plus epistasis rescue in p21-null cells, single lab, two orthogonal methods\",\n      \"pmids\": [\"14726710\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"BCCIP regulates p21 expression through a p53-dependent mechanism. RNAi-mediated partial knockdown of BCCIP reduces p21 levels and impairs G1/S checkpoint activation in response to ionizing radiation; BCCIP was shown to regulate p53 transcriptional activity.\",\n      \"method\": \"RNA interference, RT-PCR/western blot for p21 levels, G1/S checkpoint assay after ionizing radiation, p53-dependent transcription reporter assay\",\n      \"journal\": \"Cell cycle (Georgetown, Tex.)\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — RNAi knockdown with defined checkpoint phenotype and p53-reporter epistasis, single lab, multiple methods\",\n      \"pmids\": [\"15539944\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"BCCIP is required for p53 transactivation activity. BCCIP knockdown by RNAi in p53 wild-type cells diminishes p53 transactivation without reducing p53 protein levels, inhibits p53 binding to the promoters of p21 and HDM2, and reduces tetrameric p53 formation.\",\n      \"method\": \"RNA interference, luciferase reporter assay, chromatin immunoprecipitation (ChIP), native PAGE for p53 tetramer assessment\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — RNAi with multiple orthogonal readouts (reporter, ChIP, tetramer), single lab but three independent methods supporting the same conclusion\",\n      \"pmids\": [\"17135243\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Multiple BCCIP domains independently regulate HR. BCCIP fragments interacting with BRCA2 or with p21 each inhibit DSB repair by HR. BCCIP does not affect non-homologous end joining (negative result). Constitutive BCCIP downregulation leads to increased spontaneous ssDNA and DSBs.\",\n      \"method\": \"Domain deletion/fragment overexpression, HR reporter assay, non-specific DNA integration assay (for NHEJ control), comet assay / ssDNA detection\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — domain-deletion functional dissection with multiple readouts, single lab\",\n      \"pmids\": [\"17947333\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"BCCIP downregulation leads to chromosomal polyploidization, centrosome amplification, and abnormal mitotic spindle formation. BCCIP-knockdown cells enter mitosis and retain spindle checkpoint but fail to complete cytokinesis.\",\n      \"method\": \"RNAi knockdown, chromosome karyotyping, centrosome immunofluorescence, spindle checkpoint assay, live-cell imaging of cytokinesis\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — RNAi with multiple specific cytological readouts (ploidy, centrosome, cytokinesis), single lab\",\n      \"pmids\": [\"17452982\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"RAD51 colocalizes with BCCIP early after ionizing radiation, and with RAD52 later. FRAP analysis shows BCCIP mobility does not change after hydroxyurea or ionizing radiation, whereas RAD52 mobility is reduced more by hydroxyurea. These data indicate temporally distinct RAD51-BCCIP and RAD51-RAD52 responses.\",\n      \"method\": \"Immunofluorescence colocalization, FRAP (fluorescence recovery after photobleaching)\",\n      \"journal\": \"Cancer research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct live-cell FRAP plus colocalization with temporal resolution, single lab, two orthogonal methods\",\n      \"pmids\": [\"18413737\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"LYRIC/AEG-1 interacts with BCCIP and promotes proteasomal degradation of BCCIPα. Co-expression reduces BCCIPα protein levels, an effect partially abrogated by proteasome inhibition; a truncated LYRIC/AEG-1 lacking the interaction region did not alter BCCIPα levels.\",\n      \"method\": \"Yeast two-hybrid, co-immunoprecipitation, proteasome inhibitor rescue, truncation mutant analysis\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — Co-IP plus domain truncation and pharmacological rescue, single lab, moderate mechanistic depth\",\n      \"pmids\": [\"18440304\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"BCCIP interacts with receptor protein tyrosine phosphatase PTPmu. BCCIP is phosphorylated by Src tyrosine kinase and dephosphorylated by PTPmu in vitro. BCCIP is required for both permissive and repulsive functions of PTPmu in neurite outgrowth.\",\n      \"method\": \"Yeast two-hybrid, in vitro GST pulldown, in vitro kinase/phosphatase assay, neurite outgrowth assay with BCCIP knockdown\",\n      \"journal\": \"Journal of cellular biochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1-2 / Moderate — in vitro kinase/phosphatase assay plus functional neurite outgrowth epistasis, single lab with multiple orthogonal methods\",\n      \"pmids\": [\"18773424\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"BCCIP is required for nuclear localization of p21. BCCIP downregulation reduces nuclear p21 and increases cytoplasmic p21. BCCIP-p21 interaction is enhanced in response to DNA damage (measured by FRET). This redistribution is not due to Thr-145 phosphorylation of p21.\",\n      \"method\": \"FRET (Fluorescence Resonance Energy Transfer), subcellular fractionation, immunofluorescence, RNAi knockdown, exogenous p21 expression\",\n      \"journal\": \"Cell cycle (Georgetown, Tex.)\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — FRET for interaction plus fractionation for localization, RNAi, single lab with orthogonal methods\",\n      \"pmids\": [\"19713748\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"BCCIP deficiency in mouse embryonic fibroblasts causes a ~20-fold increase in sister chromatid union (SCU), 3.5-fold increase in chromatid breaks, reduced repair of irradiation-induced DNA damage, reduced RAD51 protein and nuclear foci, and impaired cell proliferation. p53 deletion cannot rescue embryonic lethality from BCCIP deficiency.\",\n      \"method\": \"Conditional knockdown transgenic mouse (Cre-LoxP RNAi), chromosome stability analysis, sister chromatid exchange assay, RAD51 immunofluorescence, p53 knockout epistasis\",\n      \"journal\": \"PLoS genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — in vivo conditional knockdown mouse model with multiple orthogonal cytological and molecular readouts and genetic epistasis, single lab but comprehensive study\",\n      \"pmids\": [\"21966279\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"BCCIP deficiency in the mouse neural system impairs embryonic and postnatal neural development, causing microcephaly and cerebellar defects associated with spontaneous DNA damage and cell death in proliferative neural progenitors. BCCIP deficiency impairs neural progenitor self-renewal and spontaneously activates p53.\",\n      \"method\": \"Conditional BCCIP knockdown mouse model (Cre-LoxP), neural spheroid culture, immunofluorescence for DNA damage markers, p53 activation assay\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vivo conditional KD with tissue-specific phenotype and in vitro progenitor assay, single lab\",\n      \"pmids\": [\"22292003\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Conditional BCCIP knockdown combined with p53 deletion causes rapid medulloblastoma development with Sonic Hedgehog pathway alterations. Progressed tumors spontaneously lose the BCCIP knockdown cassette and restore BCCIP expression, demonstrating that transient BCCIP downregulation is sufficient to initiate tumorigenesis but BCCIP is required for tumor progression.\",\n      \"method\": \"Conditional knockdown transgenic mouse model, tumor histology, genomic analysis of Shh pathway, loss of knockdown cassette verification by PCR\",\n      \"journal\": \"Cancer research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vivo conditional model with molecular verification of cassette loss, single lab\",\n      \"pmids\": [\"24145349\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"BCCIPβ, but not BCCIPα, forms a ternary complex with ribosomal protein RPL23/uL14 and pre-60S trans-acting factor eIF6 in a manner dependent on the intact C-terminal domain of BCCIPβ. BCCIPβ depletion reduces the free RPL23 pool and decreases nucleolar eIF6 levels. BCCIPβ overexpression leads to nucleoplasmic accumulation of extra-ribosomal RPL23, indicating BCCIPβ functions as a nuclear chaperone for RPL23.\",\n      \"method\": \"Co-immunoprecipitation, subcellular fractionation, overexpression/depletion experiments, immunofluorescence\",\n      \"journal\": \"FEBS letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP for ternary complex plus depletion/overexpression with defined molecular phenotypes, single lab\",\n      \"pmids\": [\"25150171\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"BCCIPβ directly binds DNA and physically interacts with RAD51 to stimulate its homologous DNA pairing activity. BCCIPβ induces a conformational change within the RAD51 filament that promotes ADP release, thereby helping maintain an active presynaptic filament (stimulation is not due to filament stabilization).\",\n      \"method\": \"In vitro DNA binding assay, pulldown, in vitro D-loop/strand exchange assay, ATPase assay, filament conformational analysis\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — reconstituted in vitro biochemical assays (DNA pairing, ADP release, conformational change), single lab with multiple orthogonal in vitro methods\",\n      \"pmids\": [\"27694622\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"The INO80/YY1 chromatin remodeling complex transcriptionally regulates BCCIP expression. YY1 and INO80 are enriched at +0.17 kb downstream of the BCCIP transcriptional start site. Both INO80 and YY1 are required for recruiting the complex to the BCCIP promoter region; knockdown of either abolishes BCCIP mRNA and protein expression.\",\n      \"method\": \"siRNA knockdown, luciferase reporter assay, chromatin immunoprecipitation (ChIP), overexpression studies\",\n      \"journal\": \"Protein & cell\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP plus luciferase reporter and knockdown, single lab with multiple orthogonal methods\",\n      \"pmids\": [\"27535137\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"BCCIPα localizes to the mitotic spindle pole and centrosome (proximal to the mother centriole). BCCIP depletion causes disoriented mitotic spindles, chromosome congression defects, and delayed mitotic progression, indicating BCCIP participates in microtubule organization.\",\n      \"method\": \"Immunofluorescence/confocal microscopy for spindle/centrosome localization, RNAi knockdown, time-lapse imaging of mitotic progression\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct localization to centrosome/spindle pole plus RNAi phenotype with specific cytological readouts, single lab\",\n      \"pmids\": [\"28394342\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"BCCIP directly interacts with YY1 via its ICD domain. BCCIP stabilizes YY1 by reducing YY1 ubiquitination, and YY1 in turn recruits itself to the BCCIP promoter to activate BCCIP transcription (BCCIP-YY1 autoregulatory feedback loop). BCCIP itself binds the BCCIP promoter in a YY1-dependent fashion.\",\n      \"method\": \"Co-immunoprecipitation, ChIP, luciferase reporter assay, ubiquitination assay, domain mapping with truncation constructs\",\n      \"journal\": \"The FEBS journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP, ChIP, reporter assay, ubiquitination assay, single lab with multiple orthogonal methods\",\n      \"pmids\": [\"29932276\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"YY1 and BCCIP coordinately regulate p53-responsive element (p53RE)-mediated transactivation of p21. YY1, BCCIP, and p53 form cross-interacting complexes; YY1 inhibits while BCCIP enhances p53RE-mediated luciferase activity. BCCIP knockdown inhibits p53 and YY1 recruitment to the p53RE proximal region of p21 promoter.\",\n      \"method\": \"Co-immunoprecipitation, dual luciferase assay, ChIP, lentiviral shRNA knockdown, rescue by YY1 overexpression\",\n      \"journal\": \"International journal of molecular sciences\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP plus reporter assay and Co-IP, single lab with multiple orthogonal methods\",\n      \"pmids\": [\"31035388\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"A fraction of BCCIP localizes in the nucleolus and is required for a pre-rRNA processing step that produces 12S pre-rRNA (precursor to 5.8S rRNA) and for 60S ribosome biogenesis. Abrogation of BCCIP nucleolar localization or impaired BCCIP-eIF6 interaction compromises eIF6 recruitment to the nucleolus and 60S biogenesis.\",\n      \"method\": \"Subcellular fractionation and immunofluorescence for nucleolar localization, pre-rRNA processing assay (northern blot/PCR), eIF6 interaction mapping, conditional knockout MEFs\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — direct nucleolar localization plus functional pre-rRNA processing assay plus eIF6 interaction mapping, single lab with multiple orthogonal methods and in vivo mouse validation\",\n      \"pmids\": [\"33245766\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Complete deletion of Bccip in adult mouse intestinal epithelium causes rapid epithelial denudation (not rescued by Trp53 co-deletion), loss of proliferative capability of crypt progenitors, loss of crypt base columnar stem cell markers, and failure of crypt organoid growth in vitro. RNA-Seq showed overwhelming down-regulation of mitotic division genes.\",\n      \"method\": \"Conditional knockout mouse (Rosa26-CreERT2, Villin-CreERT2), crypt organoid culture, immunofluorescence, RNA-Seq\",\n      \"journal\": \"The American journal of pathology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vivo conditional knockout with tissue-specific phenotype plus in vitro organoid assay and RNA-Seq, single lab\",\n      \"pmids\": [\"33039352\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Crystal structures of N-terminal truncated human BCCIPβ (residues 61-314) show structural similarity to GCN5-related acetyltransferases (GNATs) but with altered acetyl-CoA and substrate-binding grooves. BCCIPβ contains a large 19-residue flap that adopts open or closed conformations and a positively charged, reduced substrate binding groove, suggesting binding sites for partner proteins.\",\n      \"method\": \"X-ray crystallography (two crystal structures solved)\",\n      \"journal\": \"Protein science : a publication of the Protein Society\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — crystal structure determination with structural analysis of functional sites, single lab rigorous structural study\",\n      \"pmids\": [\"33452718\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"BCCIP is recruited to stalled replication forks and prevents MRE11 nuclease-mediated degradation of nascent DNA strands. BCCIP deficiency increases replication fork stalling and results in DNA double-strand break formation under replication stress.\",\n      \"method\": \"DNA fiber assay, iPOND (or proximity-ligation assay for fork recruitment), MRE11 inhibitor/knockdown epistasis, γH2AX staining\",\n      \"journal\": \"FEBS letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — DNA fiber assay plus epistasis with MRE11, single lab with defined molecular mechanism\",\n      \"pmids\": [\"35592921\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"BCCIPα, but not BCCIPβ, binds FAM46 (TENT5) family noncanonical poly(A) polymerases and inhibits their PAP activity. Crystal structures of FAM46A/BCCIPα and FAM46C/BCCIPα complexes show BCCIPα adopts a unique fold (completely different from BCCIPβ) due to its distinct C-terminal segment; a helix-loop-helix segment in BCCIPα inserts into the active site cleft of FAM46 to inhibit PAP activity. The distinct C-terminal segment supports fold adoption but does not directly contact FAM46.\",\n      \"method\": \"X-ray crystallography (two complex structures), in vitro PAP activity assay, domain mutagenesis, isoform-specific binding assay\",\n      \"journal\": \"Science advances\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — crystal structure of two distinct complexes plus in vitro enzymatic inhibition assay and mutagenesis, single lab but multiple rigorous orthogonal methods\",\n      \"pmids\": [\"37018411\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"BCCIP is a nuclear protein that exists as two alternatively spliced isoforms (BCCIPα and BCCIPβ) with shared ICD but distinct C-terminal domains: BCCIPα uniquely folds to bind and inhibit FAM46/TENT5 poly(A) polymerases and localizes to mitotic spindle poles, while BCCIPβ acts as a nuclear chaperone for RPL23 and directly stimulates RAD51 homologous pairing by inducing ADP release from the presynaptic filament; both isoforms interact with BRCA2 and p21 to promote RAD51/BRCA2 focus formation, homologous recombination repair of DSBs, protection of nascent DNA at stalled replication forks, p53 tetramerization and transactivation of p21, and G1/S checkpoint control, while a fraction of BCCIP localizes to the nucleolus to interact with eIF6 and drive 12S pre-rRNA processing and 60S ribosome biogenesis, explaining why partial BCCIP loss triggers genomic instability and tumorigenesis whereas complete loss is lethal.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"BCCIP is a nuclear protein that integrates DNA double-strand break repair, cell-cycle checkpoint control, ribosome biogenesis, and mitotic fidelity, and exists as two alternatively spliced isoforms (BCCIPα/TOK-1α and BCCIPβ) sharing an internal conserved domain but differing in their C-termini [#0, #2]. Through a shared region both isoforms bind the internal conserved region of BRCA2, and their depletion sharply reduces RAD51 and BRCA2 nuclear focus formation and homologous recombination repair of DSBs without affecting non-homologous end joining [#0, #2, #6]. BCCIPβ acts directly at the recombination step: it binds DNA and RAD51 and stimulates RAD51 homologous pairing by inducing a filament conformational change that promotes ADP release to maintain an active presynaptic filament [#16]. Beyond canonical break repair, BCCIP is recruited to stalled replication forks and protects nascent DNA from MRE11-mediated degradation [#24]. In cell-cycle control, the α isoform binds the C-terminus of p21 and cooperatively enhances p21-dependent inhibition of CDK2, while BCCIP is required for nuclear localization of p21, for p53 tetramerization, and for p53-dependent transactivation of p21 and HDM2, thereby enforcing the G1/S checkpoint after ionizing radiation [#1, #5, #11]. The two isoforms are also functionally specialized in other compartments: BCCIPβ serves as a nuclear chaperone for ribosomal protein RPL23/uL14 and, in the nucleolus, drives 12S pre-rRNA processing and 60S ribosome biogenesis through recruitment of eIF6 [#15, #21], whereas BCCIPα localizes to the mitotic spindle pole and centrosome and binds and inhibits FAM46/TENT5 poly(A) polymerases via an isoform-specific fold [#18, #25]. BCCIP expression is set by an INO80/YY1-driven autoregulatory transcriptional circuit [#17, #19]. In vivo, partial BCCIP loss produces genomic instability, chromosomal aberrations, and tumorigenesis, while complete loss is lethal to proliferative tissues and is not rescued by p53 deletion [#12, #14, #22].\",\n  \"teleology\": [\n    {\n      \"year\": 2000,\n      \"claim\": \"Established the first molecular partner of the α isoform, defining BCCIP as a CDK-inhibitory cofactor by showing it strengthens p21 action.\",\n      \"evidence\": \"Yeast two-hybrid cloning, ternary-complex co-IP, and in vitro CDK2 histone H1 kinase assay\",\n      \"pmids\": [\"10878006\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not address the β isoform or DNA-repair roles\", \"No structural basis for the p21 interaction\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Identified BCCIPα as a BRCA2-interacting nuclear protein whose overexpression suppresses cancer cell growth, linking BCCIP to the BRCA2 axis and tumor suppression.\",\n      \"evidence\": \"Yeast two-hybrid, subcellular fractionation/immunofluorescence, growth inhibition assays\",\n      \"pmids\": [\"11313963\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Functional consequence of the BRCA2 interaction not yet tested\", \"Domain architecture defined but functions of NAD/ICD/CVD unassigned\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Connected BCCIP to checkpoint control by showing it regulates p21 in a p53-dependent manner and that the β isoform delays G1/S progression.\",\n      \"evidence\": \"RNAi knockdown, p21-null rescue, flow cytometry, p53 reporter assay after ionizing radiation\",\n      \"pmids\": [\"14726710\", \"15539944\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism of p53 regulation unresolved at this stage\", \"Did not separate checkpoint role from repair role\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Demonstrated that both isoforms bind BRCA2 and are quantitatively required for RAD51/BRCA2 focus formation and HRR, placing BCCIP functionally in the homologous recombination pathway.\",\n      \"evidence\": \"Reciprocal co-IP, RNAi, immunofluorescence colocalization, HRR reporter assay\",\n      \"pmids\": [\"15713648\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether BCCIP acts directly on RAD51 or via BRCA2 not yet distinguished\", \"Step in HR affected unknown\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Resolved the p53 regulatory mechanism by showing BCCIP is required for p53 tetramerization and promoter binding rather than p53 stabilization.\",\n      \"evidence\": \"RNAi, luciferase reporter, ChIP, native PAGE for tetramer assessment\",\n      \"pmids\": [\"17135243\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How BCCIP promotes tetramer formation mechanistically unknown\", \"Direct vs indirect p53 contact not established\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Dissected BCCIP domains in HR and revealed that its loss drives genomic instability through spindle/centrosome defects and failed cytokinesis, broadening its role beyond repair.\",\n      \"evidence\": \"Domain-fragment overexpression with HR/NHEJ reporters and comet assay; RNAi with karyotyping, centrosome IF, and cytokinesis imaging\",\n      \"pmids\": [\"17947333\", \"17452982\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Molecular target at the spindle/centrosome unidentified\", \"Link between repair defect and ploidy defect not mechanistically connected\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Defined temporal dynamics of BCCIP at damage sites and identified upstream and signaling partners (LYRIC/AEG-1 degradation, PTPmu/Src phosphorylation).\",\n      \"evidence\": \"Immunofluorescence/FRAP at damage sites; co-IP, proteasome rescue, in vitro kinase/phosphatase assays, neurite outgrowth assay\",\n      \"pmids\": [\"18413737\", \"18440304\", \"18773424\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Physiological significance of Src/PTPmu phosphorylation unclear\", \"How AEG-1-driven degradation is regulated in vivo unknown\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Showed BCCIP controls the subcellular distribution of p21, with a DNA-damage-enhanced interaction driving p21 nuclear retention independent of Thr-145 phosphorylation.\",\n      \"evidence\": \"FRET, subcellular fractionation, immunofluorescence, RNAi\",\n      \"pmids\": [\"19713748\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism by which damage enhances the interaction unknown\", \"Transport machinery involved not identified\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Provided in vivo confirmation that BCCIP maintains chromosome stability and RAD51 function, and that its essentiality is p53-independent.\",\n      \"evidence\": \"Conditional knockdown mouse, sister chromatid union/break analysis, RAD51 IF, p53 knockout epistasis\",\n      \"pmids\": [\"21966279\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Cause of p53-independent lethality not defined\", \"Tissue specificity of phenotype not yet explored\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Established BCCIP as a tumor suppressor whose transient loss initiates medulloblastoma but whose expression is required for tumor progression.\",\n      \"evidence\": \"Conditional knockdown mouse with p53 deletion, tumor histology, Shh pathway analysis, cassette-loss verification\",\n      \"pmids\": [\"24145349\", \"22292003\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism linking BCCIP loss to Shh alterations unknown\", \"Why progression requires BCCIP re-expression not resolved\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Identified an isoform-specific role for BCCIPβ as a nuclear chaperone for RPL23 acting with eIF6, first connecting BCCIP to ribosome biogenesis.\",\n      \"evidence\": \"Co-IP of ternary complex, fractionation, overexpression/depletion, immunofluorescence\",\n      \"pmids\": [\"25150171\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Effect on mature ribosome output not measured here\", \"Whether chaperone role contributes to genomic-instability phenotype unknown\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Provided the mechanistic basis for BCCIP's HR function and revealed transcriptional control of the gene by INO80/YY1.\",\n      \"evidence\": \"Reconstituted in vitro DNA-binding, strand-exchange, ATPase, and filament conformation assays; siRNA, ChIP, reporter assays\",\n      \"pmids\": [\"27694622\", \"27535137\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How BCCIPβ recognizes the presynaptic filament structurally not determined\", \"Integration of transcriptional control with damage signaling unknown\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Localized BCCIPα to the mitotic spindle pole/centrosome, assigning a direct mitotic role to the α isoform.\",\n      \"evidence\": \"Confocal IF localization, RNAi, time-lapse mitotic imaging\",\n      \"pmids\": [\"28394342\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Spindle-pole binding partner not identified\", \"Mechanism of microtubule organization unresolved\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Detailed the BCCIP-YY1 regulatory circuit, including an autoregulatory feedback loop and coordinate control of p53RE-mediated p21 transactivation.\",\n      \"evidence\": \"Co-IP, ChIP, reporter and ubiquitination assays, domain mapping, shRNA with rescue\",\n      \"pmids\": [\"29932276\", \"31035388\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"How opposing YY1/BCCIP effects on p53RE are balanced unknown\", \"In vivo relevance of the feedback loop not tested\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Defined BCCIP's nucleolar role in 12S pre-rRNA processing and 60S biogenesis and showed that complete loss is catastrophic for proliferative stem/progenitor tissue.\",\n      \"evidence\": \"Fractionation/IF, pre-rRNA processing assay, eIF6 interaction mapping, conditional knockout MEFs and intestinal epithelium with organoids and RNA-Seq\",\n      \"pmids\": [\"33245766\", \"33039352\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether the ribosome defect underlies the lethality of complete loss not directly tested\", \"Relationship between nucleolar and repair functions unresolved\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Provided the first structure of BCCIPβ, revealing a GNAT-like fold with altered substrate/cofactor grooves and a conformationally dynamic flap implicated in partner binding.\",\n      \"evidence\": \"Two X-ray crystal structures of N-terminally truncated BCCIPβ\",\n      \"pmids\": [\"33452718\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No demonstrated acetyltransferase activity despite GNAT similarity\", \"Partner-bound structures not solved\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Extended BCCIP's genome-protective role to replication stress by showing it shields nascent DNA from MRE11 nuclease at stalled forks.\",\n      \"evidence\": \"DNA fiber assay, MRE11 epistasis, γH2AX staining\",\n      \"pmids\": [\"35592921\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism of fork recruitment not defined\", \"Which isoform mediates fork protection unknown\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Defined the structural basis for isoform divergence, showing BCCIPα adopts a unique fold that inhibits FAM46/TENT5 poly(A) polymerases, a function exclusive to the α isoform.\",\n      \"evidence\": \"Crystal structures of FAM46A/C–BCCIPα complexes, in vitro PAP assays, mutagenesis, isoform-specific binding\",\n      \"pmids\": [\"37018411\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Cellular consequences of FAM46 inhibition by BCCIPα untested\", \"How the α-specific function integrates with mitotic localization unknown\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How BCCIP's distinct activities — HR stimulation, replication-fork protection, p53/p21 checkpoint control, ribosome biogenesis, mitotic spindle organization, and FAM46 inhibition — are coordinated within a cell and which is rate-limiting for the essentiality and tumor-suppressor phenotypes remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No unified model reconciling the multiple compartment-specific functions\", \"Biochemical activity of the GNAT-like fold undefined\", \"Relative contribution of each function to lethality vs tumorigenesis unknown\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [16]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [1, 16, 25]},\n      {\"term_id\": \"GO:0044183\", \"supporting_discovery_ids\": [15]},\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [5, 20]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [0, 2]},\n      {\"term_id\": \"GO:0005730\", \"supporting_discovery_ids\": [15, 21]},\n      {\"term_id\": \"GO:0005815\", \"supporting_discovery_ids\": [18]},\n      {\"term_id\": \"GO:0005654\", \"supporting_discovery_ids\": [11, 15]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-73894\", \"supporting_discovery_ids\": [2, 6, 16]},\n      {\"term_id\": \"R-HSA-1640170\", \"supporting_discovery_ids\": [3, 4, 7, 18]},\n      {\"term_id\": \"R-HSA-8953854\", \"supporting_discovery_ids\": [15, 21]},\n      {\"term_id\": \"R-HSA-69306\", \"supporting_discovery_ids\": [24]},\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [5, 17, 19, 20]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"BRCA2\", \"RAD51\", \"CDKN1A\", \"TP53\", \"YY1\", \"RPL23\", \"EIF6\", \"FAM46C\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":8,"faith_total":8,"faith_pct":100.0}}